BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37006254)

  • 21. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin.
    Janovska P; Melenovsky V; Svobodova M; Havlenova T; Kratochvilova H; Haluzik M; Hoskova E; Pelikanova T; Kautzner J; Monzo L; Jurcova I; Adamcova K; Lenkova L; Buresova J; Rossmeisl M; Kuda O; Cajka T; Kopecky J
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1614-1627. PubMed ID: 33084249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cachexia on bone turnover in cancer patients: a case-control study.
    Zwickl H; Zwickl-Traxler E; Haushofer A; Seier J; Podar K; Weber M; Hackner K; Jacobi N; Pecherstorfer M; Vallet S
    BMC Cancer; 2021 Jun; 21(1):744. PubMed ID: 34182958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
    Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil activation in morbid obesity, chronic activation of acute inflammation.
    Nijhuis J; Rensen SS; Slaats Y; van Dielen FM; Buurman WA; Greve JW
    Obesity (Silver Spring); 2009 Nov; 17(11):2014-8. PubMed ID: 19390527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
    Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
    Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.
    Dolly A; Lecomte T; Tabchouri N; Caulet M; Michot N; Anon B; Chautard R; Desvignes Y; Ouaissi M; Fromont-Hankard G; Dumas JF; Servais S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1837-1849. PubMed ID: 35316572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor protein function in skeletal abdominal muscle of cachectic cancer patients.
    Taskin S; Stumpf VI; Bachmann J; Weber C; Martignoni ME; Friedrich O
    J Cell Mol Med; 2014 Jan; 18(1):69-79. PubMed ID: 24251822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival.
    Judge SM; Nosacka RL; Delitto D; Gerber MH; Cameron ME; Trevino JG; Judge AR
    JNCI Cancer Spectr; 2018 Jul; 2(3):pky043. PubMed ID: 30637373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylethanolamine (18:2e/18:2) may inhibit adipose tissue wasting in patients with cancer cachexia by increasing lysophosphatidic acid receptor 6.
    Ding Z; Han J; Huang Q; Liu X; Sun D; Sui X; Zhuang Q; Wu G
    Nutrition; 2024 Apr; 120():112356. PubMed ID: 38354460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia.
    Wang D; Li X; Jiao D; Cai Y; Qian L; Shen Y; Lu Y; Zhou Y; Fu B; Sun R; Tian Z; Zheng X; Wei H
    J Hematol Oncol; 2023 Mar; 16(1):30. PubMed ID: 36973755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure - is there only one cachexia?
    Letilovic T; Perkov S; Mestric ZF; Vrhovac R
    Nutr J; 2013 Jan; 12():6. PubMed ID: 23294910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
    Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
    J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
    Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.